SOLBAR
Nonprescription drug in Canada (DIN); Approved: 27 February 2002
A nonprescription drug in Canada may have a cancelled status. Their presence does not demonstrate current sales. The DIN is the drug identification number printed on the packaging. The analysis indicates what the annexes to Regulation (EC) No 1223/2009 would require if this product were sold as a cosmetic in France. It does not assess its Canadian authorisation and does not constitute authorisation for sale in France. Only active ingredients are published in these extracts; the full formula and other conditions of use remain to be checked. No strength is estimated.
Drug Product Database, Canadian non-prescription drugs with cosmetic uses, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, DPD)
- DIN
- 02245609
- Trade name
- SOLBAR
- Company
- SEAFORD PHARMACEUTICALS INC
- Current status
- Approved: 27 February 2002
- Product update in the source
- 22 March 2025
- Form
- Crème
- Routes
- Topique
- ATC classes
- D02BA30 : French label not published
Status history
- Approved: 27 February 2002; current status
Published active ingredients and strengths
| Published active ingredient | Published strength | Percentage conversion |
|---|---|---|
| HOMOSALATE | 10 % | 10 % (unspecified basis) |
| OCTINOXATE | 7.5 % | 7,5 % (unspecified basis) |
| ZINC OXIDE | 7.5 % | 7,5 % (unspecified basis) |
Mass/volume percentages are not treated as mass/mass percentages. A strength expressed as base is not converted to the strength of the salt or compound.
Cosmetic analysis in the European Union
- HOMOSALATE : Filtre UV autorisé sous les conditions de l’annexe VI du règlement (CE) 1223/2009.
- Annexe VI, entrée 3 : 7,34 % ; seulement pour : Face products with the exception of propellent spray products ; From 1 January 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 July 2025 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market. ; comparaison de teneur non établie sans estimation.
- OCTINOXATE : Filtre UV autorisé sous les conditions de l’annexe VI du règlement (CE) 1223/2009.
- Annexe VI, entrée 12 : 10 % ; comparaison de teneur non établie sans estimation.
- ZINC OXIDE : Filtre UV autorisé sous les conditions de l’annexe VI du règlement (CE) 1223/2009.
- Annexe VI, entrée 30 : - 25 % - In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit of 25 % ; Not to be used in applications that may lead to exposure of the end-user's lungs by inhalation. ; comparaison de teneur non établie sans estimation.
3 ingredients allowed under conditions (maximum concentration, product types): some active ingredient concentrations are printed; the other conditions and the product's classification in the European Union remain to be checked. 3 names recognised out of 3.
HOMOSALATE, ETHYLHEXYL METHOXYCINNAMATE, ZINC OXIDE
Who it concerns
For each group, the ingredients of the list that an official classification or rule mentions. Open an ingredient's page to read what the text says. A group with no name does not mean the ingredients were judged to have no effect for it.
Prohibition or serious classificationThe text prohibits the substance for this use, or ranks it among the most serious hazards (known or presumed carcinogenic, mutagenic or reprotoxic, identified endocrine disruptor).Worth watchingThe text sets a condition or flags a hazard worth knowing: allergen, suspected effect, condition for children, hazard to the aquatic environment.For informationOfficial information with no condition on a finished product: warning to read, irritation of the pure substance.
Environment
- Worth watching ZINC OXIDEClassified under the CLP Regulation: hazardous to the aquatic environment, short term, category 1 (Aquatic Acute 1); hazardous to the aquatic environment, long term, category 1 (Aquatic Chronic 1).
No official text covers the recognised ingredients for: pregnancy and breastfeeding, babies and children, skin, eyes and allergies, read on the label.
For a question about your own situation (pregnancy, child, allergy), show this list to your doctor, midwife or pharmacist: we cannot say whether this product suits you.
Selling elsewhere
Ingredients of this list that are prohibited, prohibited in some cases or subject to conditions in the other countries whose rules we record (nothing changes for sale in France). Absence is not approval: several countries only allow the preservatives, UV filters and colorants on their lists, and the function of an ingredient in the product is not known. What is covered for each country.
| Country | Prohibited | Prohibited in some cases | Subject to conditions |
|---|---|---|---|
| United Kingdom | - | - | HOMOSALATE, ETHYLHEXYL METHOXYCINNAMATE, ZINC OXIDE |
| South Korea | - | - | HOMOSALATE, ETHYLHEXYL METHOXYCINNAMATE, ZINC OXIDE |
| Australia | - | - | HOMOSALATE, ZINC OXIDE |
| ASEAN | - | - | HOMOSALATE, ETHYLHEXYL METHOXYCINNAMATE, ZINC OXIDE |
| Taiwan | - | - | HOMOSALATE, ETHYLHEXYL METHOXYCINNAMATE, ZINC OXIDE |
| Brazil | - | - | HOMOSALATE, ETHYLHEXYL METHOXYCINNAMATE, ZINC OXIDE |
No prohibition or condition found in the recorded lists for: United States (federal), Washington State, California, Canada, Japan, China.
Ingredient by ingredient
The line under each name gives its rule in the European Union (legend below). Click a name for its page.
Hover over or tap a badge for its meaning.
Classified hazard (cancer, DNA, reproduction): Carcinogenic, mutagenic or toxic for reproduction under the CLPEU regulation that classifies chemicals by their hazards (EC No 1272/2008). Regulation, or identified endocrine disruptor. Irritation, allergy and environment: see “Who it concerns”.
| On the label | Glossary name | Rule in the European Union | Classified hazard (cancer, DNA, reproduction) |
|---|---|---|---|
| HOMOSALATE | HOMOSALATE | UV filter allowed under conditions (Annex VI) Annex VI, entry 3: products: Face products with the exception of propellent spray products; maximum concentration: 7.34% | none |
| ETHYLHEXYL METHOXYCINNAMATE | ETHYLHEXYL METHOXYCINNAMATE | UV filter allowed under conditions (Annex VI) Annex VI, entry 12: maximum concentration: 10% | none |
| ZINC OXIDE | ZINC OXIDE | UV filter allowed under conditions (Annex VI) Colorant allowed under conditions (Annex IV) Separate entry for the nano form (Annex VI) Annex VI, entry 30: maximum concentration: - 25% - In case of combined use of zinc oxide and zinc oxide (nano), the sum shall not exceed the limit of 25% | none |
Official Drug Product Database record.
Contient des informations visées par la Licence du gouvernement ouvert – Canada (Santé Canada, BDPP).